相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Advances in osteosarcoma stem cell research and opportunities for novel therapeutic targets
Guang-Ning Yan et al.
CANCER LETTERS (2016)
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma
Ilaria Buondonno et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Hypoxia-Induced WSB1 Promotes the Metastatic Potential of Osteosarcoma Cells
Ji Cao et al.
CANCER RESEARCH (2015)
Cambogin Induces Caspase-Independent Apoptosis through the ROS/JNK Pathway and Epigenetic Regulation in Breast Cancer Cells
Kaikai Shen et al.
MOLECULAR CANCER THERAPEUTICS (2015)
E2F1 impairs all-trans retinoic acid-induced osteogenic differentiation of osteosarcoma via promoting ubiquitination-mediated degradation of RARα
Lei Zhang et al.
CELL CYCLE (2014)
Pharmacological targeting of endoplasmic reticulum stress signaling in cancer
Axel H. Schoenthal
BIOCHEMICAL PHARMACOLOGY (2013)
Bortezomib Sensitizes Human Acute Myeloid Leukemia Cells to All-Trans-Retinoic Acid-Induced Differentiation by Modifying the RARα/STAT1 Axis
Meidan Ying et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Bortezomib and SAHA Synergistically Induce ROS-Driven Caspase-Dependent Apoptosis of Nasopharyngeal Carcinoma and Block Replication of Epstein-Barr Virus
Kwai Fung Hui et al.
MOLECULAR CANCER THERAPEUTICS (2013)
AMPK and Akt Determine Apoptotic Cell Death following Perturbations of One-Carbon Metabolism by Regulating ER Stress in Acute Lymphoblastic Leukemia
Jeffim N. Kuznetsov et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Thiazole Antibiotic Thiostrepton Synergize with Bortezomib to Induce Apoptosis in Cancer Cells
Bulbul Pandit et al.
PLOS ONE (2011)
Synergistic Anti-Cancer Activity by the Combination of TRAIL/APO-2L and Celastrol
Hong Zhu et al.
CANCER INVESTIGATION (2010)
Reactive oxygen species-mediated endoplasmic reticulum stress and mitochondrial dysfunction contribute to cirsimaritin-induced apoptosis in human gallbladder carcinoma GBC-SD cells
Zhiwei Quan et al.
CANCER LETTERS (2010)
Proteasome inhibition with bortezomib suppresses growth and induces apoptosis in osteosarcoma
Yuriy Shapovalov et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
被撤回的出版物: Gossypol Induces Death Receptor-5 through Activation of the ROS-ERK-CHOP Pathway and Sensitizes Colon Cancer Cells to TRAIL (Retracted article. See vol. 291, pg. 16923, 2016)
Bokyung Sung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma
Kieron Dunleavy et al.
BLOOD (2009)
ROS-driven Akt dephosphorylation at Ser-473 is involved in 4-HPR-mediated apoptosis in NB4 cells
Ji Cao et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Trends in childhood cancer incidence in the US (1992-2004)
Amy M. Linabery et al.
CANCER (2008)
Preferential Cytotoxicity of Bortezomib toward Hypoxic Tumor Cells via Overactivation of Endoplasmic Reticulum Stress Pathways
Diane R. Fels et al.
CANCER RESEARCH (2008)
Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway
Toru Akiyama et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities
Inki Kim et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Involvement of selective reactive oxygen species upstream of proapoptotic branches of unfolded protein response
Makiko Yokouchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Endoplasmic reticulum stress and oxidative stress: A vicious cycle or a double-edged sword?
Jyoti D. Malhotra et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Bortezomib for the treatment of mantle cell lymphoma
Robert C. Kane et al.
CLINICAL CANCER RESEARCH (2007)
Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-κB activation
Do-Sung Kim et al.
LIFE SCIENCES (2007)
Adriamycin-induced oxidative mitochondrial cardiotoxicity
J. M. Berthiaume et al.
CELL BIOLOGY AND TOXICOLOGY (2007)
Bortezomib as an antitumor agent
A. M. Roccaro et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2006)
The proteasome as a potential target for novel anticancer drugs and chemosensitizers
Kristin R. Landis-Piwowar et al.
DRUG RESISTANCE UPDATES (2006)
Sulforhodamine B colorimetric assay for cytotoxicity screening
Vanicha Vichai et al.
NATURE PROTOCOLS (2006)
Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells
ST Nawrocki et al.
CANCER RESEARCH (2005)
Tumor necrosis factor α (TNFα) induces the unfolded protein response (UPR) in a reactive oxygen species (ROS)-dependent fashion, and the UPR counteracts ROS accumulation by TNFα
X Xue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Osteosarcoma relapse after combined modality therapy:: An analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS)
B Kempf-Bielack et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Roles of CHOP/GADD153 in endoplasmic reticulum stress
S Oyadomari et al.
CELL DEATH AND DIFFERENTIATION (2004)
Proteasome inhibitor PS-341 induces a apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells
A Fribley et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro
P Spallarossa et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis
WP Tsang et al.
LIFE SCIENCES (2003)
分享论文
